logo
Colorado says Republican budget bill will cut billions in federal funding for Medicaid in the state

Colorado says Republican budget bill will cut billions in federal funding for Medicaid in the state

CBS News14 hours ago
State says Republican budget bill will cut billions in federal funding for Medicaid in Colorado
State says Republican budget bill will cut billions in federal funding for Medicaid in Colorado
State says Republican budget bill will cut billions in federal funding for Medicaid in Colorado
Colorado is expected to lose up to $2.5 billion dollars annually in federal Medicaid funding under the Republican Party's massive tax and spending cuts bill.
The measure passed the U.S. Senate Tuesday after Vice President JD Vance cast the tie-breaking vote.
It would extend Republican 2017 tax cuts permanently, increase funding for defense and immigration enforcement and cut funding for Medicaid, food stamps and green energy programs.
The Congressional Budget Office estimates it would increase the deficit by about $3 trillion over ten years. The bill now goes back to the U.S. House of Representatives for approval.
Among the differences between the Senate and House versions are changes to Medicaid, which provides health coverage for one in four Coloradans.
The Congressional Budget Office says the Senate bill will reduce spending on Medicaid by nearly $1 trillion over the next decade, and maybe nowhere will those cuts be felt more than in rural Colorado, where half of all hospitals are already operating in the red.
Lincoln Health in Hugo is among them. It is the only hospital on the I-70 corridor for 160 miles. The survival of those who live in the area depends on the survival of the hospital, which also operates family practice clinics, a nursing home and assisted living center.
Lincoln Health CEO Kevin Stansbury
CBS
CEO Kevin Stansbury says those services are at risk under the bill.
"We will have to close down some services," Stansbury told CBS Colorado. "And the challenge will be what services are not essential."
Stansbury says 80% of the patients at Lincoln Health are on Medicaid or Medicare.
The Colorado Department of Health Care Policy and Financing (HCPF) -- which administers Medicaid -- says the bill would mean a loss of between $900 million and $2.5 billion a year in federal funding for Medicaid. It says the state would lose another $550 million a year due to a provision that caps a fee many states assess on hospitals at 3.5%.
The bill also creates new verification requirements that HCPF says could cost the state $57 million to administer. It says the red tape will also result in thousands of Coloradans losing coverage. The bill requires recipients to provide proof they're going to school, volunteering, or working every month, and provide proof of their income and citizenship every six months.
Stansbury says some recipients in Lincoln County don't have internet and will need to travel 80 miles to Fort Morgan to re-certify in person. He says many will drop off the rolls and end up uninsured.
"Our patients have to travel to Fort Morgan for in-person revalidation of their Medicaid," Stansbury explained. "You're cutting access to care, which ironically could drive up the cost of care and put more financial stress on hospitals."
Stansbury says Lincoln Health expects to lose about 25% of its Medicaid reimbursement under the bill. While it creates a new $50 billion rural hospital fund, he says it's unclear who would qualify for the money and how it would be distributed.
"Where you live shouldn't determine if you live," Stansbury said.
He notes many of the people who live in Lincoln County are conservatives.
"I'm not sure that's what people out here voted for," Stansbury said. "I don't think they voted to have their hospital decimated."
Lincoln Health may have to scale back services, but Stansbury says the hospital will survive.
"This is a mission for us, and we're going to stick here. We're going to provide care to our patients," Stansbury said. "All we're asking is that we get paid equitably for it."
The Senate dropped a provision in the House bill that would have cut federal Medicaid funding by 10% in states like Colorado that use their own tax dollars to cover Medicaid for non-citizens.
The bill could also impact Medicare reimbursement. Because it adds to the deficit, it triggers the "Pay As You Go Act," which makes automatic cuts to federal spending. Medicare reimbursement could drop by an estimated 4%.
Stansbury says rural hospitals are not only underpaid by Medicaid and Medicare, but by commercial insurers. He says Lincoln Health receives 100% less reimbursement from commercial carriers than hospitals in the Denver metro area.
Both the Senate and House bills allow a subsidy program enacted during the COVID-19 pandemic to expire at the end of the year. It caps premiums for those who buy insurance on the Health Exchange at 8.5% of a household's income. People who live in rural or mountain communities could see their premiums double.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HRT ‘can raise breast cancer risk' in younger women
HRT ‘can raise breast cancer risk' in younger women

Yahoo

time29 minutes ago

  • Yahoo

HRT ‘can raise breast cancer risk' in younger women

Hormone replacement therapy can raise the risk of breast cancer in some younger women, a Lancet study suggests. An international team of researchers found the treatment was not linked to young onset breast cancer overall. But oestrogen plus progestin therapy appears to increase breast cancer risk by 10 per cent. Meanwhile, oestrogen hormone therapy use appeared to decrease breast cancer risk by 14 per cent. Hormone replacement therapy is a treatment used to help menopause symptoms. There are different types of HRT, which is used to treat menopause symptoms, available. They contain different hormones: some are oestrogen products; others contain progestogen and other types have both. These medicines can be taken or used in different ways and work by replacing the hormones oestrogen and progesterone, which can fall to lower levels as women approach the menopause. Most studies examining links between hormone therapy and breast cancer risk have been explored in older women. Previous work, which has focused on women who have already been through the menopause, suggest that oestrogen plus progestin hormone therapy is a risk factor for breast cancer. The researchers, led by academics from the National Institute of Environmental Health Sciences in the US, wanted to explore the risks among younger women on hormone therapy – who may take these drugs after gynaecological surgery or during perimenopause. The new meta-analysis published in the journal, Lancet Oncology, examined data drawn from previous studies of 459,476 women aged 16 to 54 years old. Some two per cent of this group (8,455) developed young-onset breast cancer, which means the disease was diagnosed before they were 55 years old. And 15 per cent of women involved in the study reported using hormone therapy, with oestrogen plus progestin hormone therapy and oestrogen being the most common types. 'Although the strength of these associations might vary by age at first use, duration of use, gynaecological surgery status, and other factors, unopposed oestrogen hormone therapy use appears to decrease breast cancer risk and oestrogen plus progestin therapy appears to increase breast cancer risk,' the authors wrote. 'The findings can be used to augment clinical recommendations for hormone therapy use in young women, for whom guidance was previously scarce.' Dr Kotryna Temcinaite, the head of research communications at Breast Cancer Now, said: 'These results are largely in line with what we already know about taking HRT for menopausal symptoms and its effects on breast cancer risk – for most people, the risk of developing breast cancer because of taking HRT is small and is outweighed by the benefits. 'Taking HRT is a very personal decision and, as such, it's vital that everyone has the information they need on the benefits and risks, discusses them with their GP or specialist team and is supported to make the choice that's right for them.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Yahoo

time30 minutes ago

  • Yahoo

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Commercial Health Benefits, Charles Kendrick, sold US$3.2m worth of shares at a price of US$432 per share. That means that an insider was selling shares at around the current price of US$396. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern. Elevance Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Over the last three months, we've seen significant insider selling at Elevance Health. Specifically, Executive VP & CFO Mark Kaye ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain. For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$103m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. An insider hasn't bought Elevance Health stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Thune says Senate Republicans have a deal to pass Trump megabill
Thune says Senate Republicans have a deal to pass Trump megabill

Yahoo

time32 minutes ago

  • Yahoo

Thune says Senate Republicans have a deal to pass Trump megabill

Senate Majority Leader John Thune (R-S.D.) told reporters Tuesday morning that he thinks he has a deal with Sen. Lisa Murkowski (R-Alaska) to pass President Trump's tax and spending megabill — but also cautioned he's a 'realist,' indicating he's not counting anything as finished until the final vote is cast. Asked if he had a deal as he walked from the Senate floor to his office, Thune replied, 'I believe we do.' 'But, like I said, I'm of Scandinavian heritage, so I'm always a bit of a realist. We'll see what happens,' he said. Live updates: After 24-hour debate, Thune ready for megabill vote; Trump heads to 'Alligator Alcatraz' Thune's body language appeared significantly more relaxed after he and Murkowski reviewed a sheet of legislative text on the Senate floor while Senate Finance Committee Chair Mike Crapo (R-Idaho) and Budget Committee Chair Lindsey Graham (R-S.C.) hovered nearby. Thune was spotted alongside Murkowski poring over the document at a desk near the back wall of the Senate chamber shortly after 8 a.m. EDT Tuesday. A person familiar with the floor conversations said the Senate parliamentarian had approved revised language to soften the impact of Medicaid cuts and food assistance cuts on Alaska. Robert Duncan, the secretary of the Republican majority, and Gary Myrick, the secretary of the Democratic conference, were spotted in a discussion with the parliamentarian at the Senate dais a short time later. The deal with Murkowski breaks a deadlock that lasted throughout Monday night and into Tuesday morning. Thune, Crapo and Senate Agriculture, Nutrition and Forestry Committee Chair John Boozman (R-Ark.) thought they had secured Murkowski's vote by crafting language to provide an enhanced federal Medicaid match for Alaska and a waiver to shield the state from Supplemental Nutrition Assistance Program (SNAP) cuts. But Senate Parliamentarian Elizabeth MacDonough threw a wrench into those plans by ruling the initial Medicaid and SNAP provisions designed to help Alaska didn't comply with the Byrd Rule and therefore weren't eligible to pass the Senate with a simple-majority vote. Republican leadership and committee staff then spent hours Monday and early Tuesday morning to craft language that could secure the approval of both Murkowski and the parliamentarian. The situation looked dire for Thune and other Republicans only a few hours earlier. Murkowski appeared to resist the entreaties of Crapo and Senate Republican Whip John Barrasso (R-Wyo.) on the floor around 3:30 a.m. before she walked into Thune's office for a meeting. When Thune and Murkowski emerged from the majority leader's office to walk back to the floor, a reporter asked Thune if he would have to pull the bill. 'Those are options I don't want to have to worry about,' Thune told reporters. Even shortly before 8 a.m. Tuesday, Thune wasn't completely sure he had Murkowski's support. A person familiar with the leadership's deliberations said Thune was planning to move forward with a vote to see for sure where Murkowski stood on the legislation after hours of haggling over Alaska-related provisions. The Senate started its marathon series of procedural and amendment votes related to the bill shortly after 9:30 a.m. Monday. Thune put the Senate chamber into an extended quorum call around 7:30 a.m. Tuesday to give senators a rest and GOP leadership staff and Finance Committee's staff more time to put the finishing touches on the deal with Murkowski and the final legislative text of the Senate bill. Thune can afford to lose three Republican votes and still pass the bill, with Vice President Vance casting a tiebreaking vote. Vance arrived at the Capitol as the sun rose. Updated at 11:29 a.m. EDT Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store